Shandong Boan Biotechnology Co., Ltd. (HKG: 6955)
Hong Kong
· Delayed Price · Currency is HKD
8.78
-0.24 (-2.66%)
Nov 15, 2024, 11:59 AM HKT
Shandong Boan Biotechnology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 172.12 | 201.85 | 233.5 | 531.7 | 3.63 |
Short-Term Investments | - | - | - | 81.86 | - |
Cash & Short-Term Investments | 172.12 | 201.85 | 233.5 | 613.56 | 3.63 |
Cash Growth | -31.14% | -13.55% | -61.94% | 16807.19% | - |
Accounts Receivable | 346.42 | 276.2 | 212.12 | 107.27 | 0.7 |
Other Receivables | - | 16.92 | 14.61 | 18.29 | 30.24 |
Receivables | 346.42 | 293.12 | 226.74 | 125.55 | 30.94 |
Inventory | 177.98 | 165.29 | 143.63 | 98.84 | 19.67 |
Other Current Assets | 52.5 | 52.75 | 242.81 | 101.9 | 37.82 |
Total Current Assets | 749.03 | 713.01 | 846.68 | 939.85 | 92.06 |
Property, Plant & Equipment | 607.84 | 627.11 | 582.69 | 521.56 | 479.08 |
Other Intangible Assets | 1,139 | 1 | 4.6 | 8.13 | 11.74 |
Long-Term Deferred Charges | - | 949.51 | 726.9 | 557.87 | 313.53 |
Other Long-Term Assets | 52.07 | 32.77 | 41.69 | 79.19 | 11.63 |
Total Assets | 2,548 | 2,323 | 2,203 | 2,107 | 908.03 |
Accounts Payable | 245.25 | 223.16 | 163.51 | 158.96 | 325.93 |
Accrued Expenses | - | 173.48 | 174.84 | 69.58 | 6.65 |
Short-Term Debt | - | 23.82 | 22.98 | - | - |
Current Portion of Long-Term Debt | 177.42 | 144.02 | 60.36 | 10 | - |
Current Portion of Leases | 2.45 | 3.57 | 8.38 | 10.02 | 7.65 |
Current Unearned Revenue | - | 12.35 | 7.02 | 1.29 | - |
Other Current Liabilities | 130.51 | 72.95 | 34.58 | 10.63 | 55.95 |
Total Current Liabilities | 555.63 | 653.35 | 471.67 | 260.48 | 396.18 |
Long-Term Debt | 476.81 | 228.32 | 210 | 240 | - |
Long-Term Leases | 5.57 | 6.18 | - | 4.5 | 8.49 |
Long-Term Unearned Revenue | 5.53 | 3 | - | 1.8 | 2.8 |
Other Long-Term Liabilities | 113.09 | 112.67 | 102.51 | 48.13 | 18.98 |
Total Liabilities | 1,157 | 1,004 | 784.18 | 554.92 | 426.44 |
Common Stock | 509.28 | 509.28 | 509.28 | 498.58 | 360 |
Additional Paid-In Capital | 1,329 | 1,329 | 1,329 | 1,162 | - |
Retained Earnings | -569.92 | -631.11 | -511.06 | -176.1 | -679.6 |
Comprehensive Income & Other | 122.95 | 112.25 | 90.71 | 67.32 | 801.18 |
Shareholders' Equity | 1,392 | 1,320 | 1,418 | 1,552 | 481.59 |
Total Liabilities & Equity | 2,548 | 2,323 | 2,203 | 2,107 | 908.03 |
Total Debt | 662.25 | 405.91 | 301.72 | 264.52 | 16.13 |
Net Cash (Debt) | -490.12 | -204.06 | -68.23 | 349.04 | -12.5 |
Net Cash Per Share | -0.96 | -0.40 | -0.14 | 0.73 | -0.32 |
Filing Date Shares Outstanding | 509.28 | 509.28 | 509.28 | 498.58 | 39.23 |
Total Common Shares Outstanding | 509.28 | 509.28 | 509.28 | 498.58 | 39.23 |
Working Capital | 193.4 | 59.66 | 375 | 679.37 | -304.12 |
Book Value Per Share | 2.73 | 2.59 | 2.79 | 3.11 | 12.28 |
Tangible Book Value | 252.32 | 1,319 | 1,414 | 1,544 | 469.85 |
Tangible Book Value Per Share | 0.50 | 2.59 | 2.78 | 3.10 | 11.98 |
Buildings | - | 126.38 | 121.38 | 121.21 | 121.02 |
Machinery | - | 625.81 | 563.21 | 470 | 391.36 |
Construction In Progress | - | 77.46 | 40.8 | 12.44 | 1.74 |
Source: S&P Capital IQ. Standard template. Financial Sources.